SKI Market

Indian Indices

Sensex

85,188.60 -32.00
( -0.04%)

Global Indices

Nasdaq

48,085.52 -302.55
(-0.63%)

Dow Jones

6,867.73 -49.51
(-0.72%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.84 -0.06
(-0.06%)

EUR-INR

105.67 -0.12
(-0.11%)

GBP-INR

121.20 -0.12
(-0.10%)

JPY-INR

0.58 0.00
(-0.05%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

37.7171887

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

8.92

17.83

EPS(TTM)

Face Value()

Div & Yield %

4.66

Back

Ultracab (India) standalone net profit declines 20.19% in the June 2025 quarter

Aug 06,2025

Net profit of Ultracab (India) declined 20.19% to Rs 1.70 crore in the quarter ended June 2025 as against Rs 2.13 crore during the previous quarter ended June 2024. Sales rose 11.99% to Rs 60.13 crore in the quarter ended June 2025 as against Rs 53.69 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	60.13	53.69	12
OPM %	6.00	7.84	-
PBDT	2.72	3.19	-15
PBT	2.35	2.92	-20
NP	1.70	2.13	-20

85,188.60 -32.00 ( -0.04%)

48,085.52 -302.55 (-0.63%)

6,867.73 -49.51 (-0.72%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.84 -0.06 (-0.06%)

105.67 -0.12 (-0.11%)

121.20 -0.12 (-0.10%)

0.58 0.00 (-0.05%)